Most Popular in the Last...

Home

Open Source Malaria (OSM)

See the following -

An Example Of Open Source Drug Discovery

Matthew Todd | Intermolecular | July 14, 2013

“Open Source Drug Discovery? How does that work?” I am asked this quite a lot. There are some principles and core practices that are involved, embodied in the Six Laws, but those are quite hifalutin. Let me give a practical example. Read More »

International Team of Scientists Open Sources Search for Malaria Cure

By Alice Williamson | June 21, 2014

The Open Source Malaria (OSM) project operates along very similar lines to traditional medicinal chemistry projects in that the team is looking for an antimalarial drug candidate suitable for Phase 1 clinical trials. However, the day to day running of the project works quite differently and is probably most clearly defined by the team’s commitment to The Six Laws of Open Science... Read More »

Open Data Key To Tackling Neglected Tropical Diseases

By Laura Owings | June 17, 2015

Open data access could promote collaborations among researchers in Africa and help in the fight against malaria, tuberculosis (TB) and neglected tropical diseases such as sleeping sickness, also called African trypanosomiasis. At a time when demand for open data in health and drug discovery is dominating the digital space, some researchers say the model could work for Africa and alleviate the sufferings of many from these diseases. Following the call on 23 April this year from the WHO for the disclosure of all results from clinical trials of new medicines, there is a push towards greater transparency.

Read More »

Open Source Malaria Project Head Wins Accelerating Science Award

Belinda Smith | The Conversation | October 22, 2013

Dr Matthew Todd – leader of the Open Source Malaria consortium in Sydney, senior lecturer at the University of Sydney and Conversation author – was awarded one of three Accelerating Science Awards in Washington DC yesterday. Read More »

Open Source Pharma And Prizes

mattoddchem | Intermolecular | May 13, 2014

I’m involved in a meeting happening next month in Italy that is asking “Can we develop a new open source pharmaceutical industry?” We’ll be talking amongst other things about incentives (such as prizes) and new ideas for the structure of pharma (legal and economic) and trying to come up with some pilot projects.

Read More »

Why Open Source Isn't The Same As Free

Matthew Todd and Abdi Ismail | The Guardian | August 14, 2013

In this week's letters, the science lead at Open Source Malaria explains the semantics of collaborative drug discovery Read More »